Marc Sze
Principal Scientist Merck & Co
Dr. Sze has spent over 7 years at Merck supporting early discovery efforts in Immuno-oncology and Immunology therapeutics areas. His team specializes in using multiple omics technologies to help research teams find novel targets, create PK/PD biomarkers for pipeline programs, and develop cutting edge methods and pipelines. His team’s work spans genomics, genetics, and proteomics-based technologies and approaches.
Seminars
Thursday 2nd April 2026
Innovative Multiomics Strategies to Accelerate Drug Development and Decode Disease Mechanisms
11:30 am
- Discover how molecular signatures across disease phenotypes inform drug response and resistance, with applications beyond primary indications
- Learn how tissue mass spectrometry and long-read sequencing offer deeper insights into disease biology and overcome limitations of traditional short-read approaches
- Explore innovative multiomics frameworks that reveal hidden patterns in unstable and fibrotic disease states, enabling more precise therapeutic development
